Valerie Rigau
Montpellier, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 127 publications
Sellar region neurocytomas exhibit a CIMP and neuroendocrine-like epigenetic signature distinct from other intra-axial neurocytomas.
Journal: Acta neuropathologica
Published: July 02, 2026
Modeling tumor volume trajectory and outcome identifies 3 distinct response classes in lower-grade IDH-mutant glioma receiving first-line chemotherapy.
Journal: Neuro-oncology advances
Published: March 30, 2026
Correlations between peripheral neuropathy profiles and vascular skin lesions.
Journal: Journal of neurology
Published: February 05, 2026
Multi-omics characterization of IDH-mutant astrocytoma-derived cell lines reveals NOTCH-regulated plastic quiescent astrocyte-like state and insights into progression.
Journal: Acta neuropathologica communications
Published: January 09, 2026
Adolescents and young adults with predominantly low grade primary central nervous system tumors: patient reported socioeconomic outcomes and health-related quality of life ten years after diagnosis.
Journal: Journal of neuro-oncology
Published: December 01, 2025
Ectopic maxillary ACTH-secreting adenoma complicated by Nelson's syndrome: A case report.
Journal: Annales d'endocrinologie
Published: November 10, 2025
Long-Term Quality of Life and Functional Outcome Analysis of Surgically Managed Central Neurocytoma Patients: Results of a Multicenter Study.
Journal: Neurosurgery
Published: May 22, 2025
Clinical value of the MGMT promoter methylation score in IDHmt low-grade glioma for predicting benefit from temozolomide treatment.
Journal: Neuro-oncology advances
Published: March 05, 2025
Nanopore sequencing as a cutting-edge technology for medulloblastoma classification.
Journal: Neuro-oncology
Published: December 28, 2024
Last Updated: 09/26/2026